Colonial Pipeline Company:石油・ガス:M&Aディール及び事業提携情報

◆英語タイトル:Colonial Pipeline Company - Oil & Gas - Deals and Alliances Profile
◆商品コード:DATA904C0063
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Colonial Pipeline Company (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services including tank leasing and new connections services. Colonial offers shipper services enabling shippers to manage product movements and inventory within enterprise resource planning system. The company also provides tank space for lease to shippers in different locations across its pipeline system. It operates through underground pipe, above ground storage tanks and pump stations. The company serves in different parts of the US. Colonial is headquartered in Alpharetta, Georgia, the US.

Colonial Pipeline Company – Oil & Gas – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Oil & Gas eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Colonial Pipeline Company, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Colonial Pipeline Company, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Colonial Pipeline Company, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Colonial Pipeline Company, Oil & Gas, Deals By Sector, 2012 to YTD 2018 8
Colonial Pipeline Company, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Colonial Pipeline Company, Oil & Gas, Deal Details 10
Asset Purchase 10
Colonial Pipeline Acquires Port Arthur Products Station and Shell Ex Facility In Texas From Shell Pipeline 10
Debt Offering 11
Colonial Pipeline Completes Private Placement Of 4.25% Senior Notes, Due 2048 For US$550 Million 11
Colonial Pipeline Completes Private Placement Of Senior Notes, Due 2025, For US$350 Million 12
Acquisition 13
Colonial Pipeline To Acquire Northstar Port Arthur From NorthStar Midstream 13
Shell Midstream Completes Acquisition Of Additional Interests In Zydeco, Bengal And Colonial From Shell Pipeline For US$700 Million 14
Shell Midstream Completes Acquisition Of Additional 19.5% Interest In Zydeco Pipeline And 1.388% Interest in Colonial Pipeline From Shell Pipeline For US$448 Million 16
Colonial Pipeline Company – Key Competitors 18
Colonial Pipeline Company – Key Employees 19
Colonial Pipeline Company – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Other Significant Developments 21
Oct 10, 2017: CTL Offers Marine Export Capabilities To Colonial Pipeline Shippers Through Enterprise Products Beaumont Terminal 21
Sep 29, 2017: Joseph A. Blount Jr. Named President & Ceo Of Colonial Pipeline Company 22
Sep 11, 2017: EIA: Hurricane Harvey Caused U.S. Gulf Coast Refinery Runs To Drop, Gasoline Prices To Rise 23
Aug 28, 2017: Colonial Pipeline Provides Update 1 On Harvey Storm 24
Jan 26, 2017: Colonial Pipeline Announces Retirement Of CEO Tim Felt 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Colonial Pipeline Company, Oil & Gas, Key Facts 2
Colonial Pipeline Company, Oil & Gas, Deals Summary, 2012 to YTD 2018 2
Colonial Pipeline Company, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Colonial Pipeline Company, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Colonial Pipeline Company, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Colonial Pipeline Company, Deals By Sector, 2012 to YTD 2018 8
Colonial Pipeline Company, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Colonial Pipeline Acquires Port Arthur Products Station and Shell Ex Facility In Texas From Shell Pipeline 10
Colonial Pipeline Completes Private Placement Of 4.25% Senior Notes, Due 2048 For US$550 Million 11
Colonial Pipeline Completes Private Placement Of Senior Notes, Due 2025, For US$350 Million 12
Colonial Pipeline To Acquire Northstar Port Arthur From NorthStar Midstream 13
Shell Midstream Completes Acquisition Of Additional Interests In Zydeco, Bengal And Colonial From Shell Pipeline For US$700 Million 14
Shell Midstream Completes Acquisition Of Additional 19.5% Interest In Zydeco Pipeline And 1.388% Interest in Colonial Pipeline From Shell Pipeline For US$448 Million 16
Colonial Pipeline Company, Key Competitors 18
Colonial Pipeline Company, Key Employees 19

List of Figures
Colonial Pipeline Company, Oil & Gas, Deals by Type, 2012 to YTD 2018 2
Colonial Pipeline Company, Oil & Gas, Deals By Year, 2012 to YTD 2018 2
Colonial Pipeline Company, Oil & Gas, Deals By Region, 2012 to YTD 2018 2
Colonial Pipeline Company, Oil & Gas, Deals By Sector, 2012 to YTD 2018 2
Colonial Pipeline Company, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Colonial Pipeline Company, Oil & Gas, Deals by Type, 2012 to YTD 2018 6
Colonial Pipeline Company, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Colonial Pipeline Company, Oil & Gas, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[Colonial Pipeline Company:石油・ガス:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mondi Limited:企業の戦略・SWOT・財務情報
    Mondi Limited - Strategy, SWOT and Corporate Finance Report Summary Mondi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cardia Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cardia Inc (Cardia) is a medical device company that designs, manufactures and markets transcatheter septal occluders for cardiac defect patients. The company offers products such as ultrasept ASD occluder, ultrasept LAA occluder, ultrasept PFO occluder, fontan occluder, ultrasept cribriform …
  • ImaginAb Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product …
  • Grupa Azoty Zaklady Chemiczne Police SA (PCE):企業の財務・戦略的SWOT分析
    Grupa Azoty Zaklady Chemiczne Police SA (PCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Aker ASA (AKER):企業の財務・戦略的SWOT分析
    Aker ASA (AKER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Impol Seval A.D. Sevojno:企業の戦略・SWOT・財務分析
    Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report Summary Impol Seval A.D. Sevojno - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • New Zealand Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, f …
  • ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析
    Summary ImmunoGen Inc (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for the treatment of various types of cancer …
  • Alfred E. Tiefenbacher GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary Alfred E. Tiefenbacher GmbH & Co KG (AET) is an independent pharmaceutical company that focuses on the development of active pharmaceuticals ingredients. It offers products in the forms of tablets, capsules, oral solution, patches, long acting injectables, ophthalmic solution and inhaled the …
  • Safe Orthopaedics SA (SAFOR):医療機器:M&Aディール及び事業提携情報
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Isuzu Motors Ltd (7202):企業の財務・戦略的SWOT分析
    Isuzu Motors Ltd (7202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Seattle Genetics Inc (SGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjugate indicated for the treatment of relapsed …
  • Sumitomo Mitsui Financial Group Inc:企業の戦略・SWOT・財務情報
    Sumitomo Mitsui Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Michael J Fox Foundation for Parkinson’s Research-医療機器分野:企業M&A・提携分析
    Summary Michael J Fox Foundation for Parkinson's Research (Michael J. Fox) is a research foundation that conducts research on Parkinson's disease. The foundation offers research and development of therapies. It provides drug development and other research activities in the area of Parkinson's diseas …
  • Shire Plc (SHP)-医療機器分野:企業M&A・提携分析
    Summary Shire Plc (Shire) is a biotechnology company that focuses on the research, development, manufacturing, marketing, distribution and sale of novel pharmaceuticals to serve patients with rare diseases and other highly specialized conditions. It provides products across various therapeutic areas …
  • Dow Inc (DOW):企業の財務・戦略的SWOT分析
    Dow Inc (DOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Cooper Tire & Rubber Company:企業の戦略・SWOT・財務情報
    Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report Summary Cooper Tire & Rubber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Currence Holding B.V.
    Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Currence Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Provence Technologies SAS-製薬・医療分野:企業M&A・提携分析
    Summary Provence Technologies SAS (ProvenceTech) is a contract research organization that provides fine organic chemistry solutions. The organization’s services include chemical development, analytical development and, global offer and consulting. It also provides research and development services. …
  • Synthetic Biologics Inc (SYN):企業の財務・戦略的SWOT分析
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆